Biogenic Gas Nanostructures As Molecular Imaging Reporters For Ultrasound
生物气体纳米结构作为超声分子成像记者
基本信息
- 批准号:8766150
- 负责人:
- 金额:$ 33.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-08-01 至 2018-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcousticsAddressAntibodiesAreaBiodistributionBiologicalBiological ModelsBiomedical EngineeringBiomedical ResearchBiophysicsBloodBlood CirculationBlood VesselsCancer Immunology ScienceCardiovascular DiseasesCell LineCell ProliferationCellsCharacteristicsChargeChemicalsClinicalCodeCommunicable DiseasesContrast MediaDetectionDevelopmentDiagnosisDiagnosticDiseaseEngineeringEventFrequenciesFutureGasesGene ClusterGene ExpressionGenesGeneticGenetic EngineeringGreen Fluorescent ProteinsHydration statusImageImaging technologyImmune System DiseasesIn VitroInferior vena cava structureLabelLiverMalignant NeoplasmsMammalian CellMethodsMicrobubblesMicrocirculationModelingModificationMolecularNanostructuresNanotechnologyNatureNerve DegenerationNeurologyPlayPropertyProteinsReporterReporter GenesResearchRoleSchemeShapesStreamStructureSurfaceTechnologyTimeTissuesToxic effectTranslationsUltrasonographyVesicleWaterWorkbasebioimagingcellular engineeringcellular imagingclinical applicationdesigndisease diagnosisimaging modalityin vivoin vivo imagingintravenous administrationmalignant breast neoplasmmicroorganismmigrationmolecular imagingnanometernanoscalenanosizedneoplastic cellnon-invasive imagingphysical propertypre-clinicalpublic health relevancetumor
项目摘要
DESCRIPTION (provided by applicant): Ultrasound is among the most widely used non-invasive imaging modalities in biomedicine, but plays a surprisingly small role in molecular imaging due to a lack of suitable molecular imaging agents. Although conventional microbubble contrast agents are gaining acceptance in non-invasive diagnosis of certain cardiovascular diseases and cancers, they have limited utility as labels of specific cells and tissues outside the
bloodstream because their micron size typically confines them to the blood stream. As a result, ultrasound has yet to fulfill its full potential to enable convenient, rapid molecular imaging in biomedical research and potential clinical areas including cancer, immunology, neurology and infectious disease. We propose to address this need by borrowing from nature. Specifically, we will develop molecular imaging agents based on a unique class of genetically encoded gas nanostructures known as gas vesicles (GVs). Expressed by aquatic microorganisms as a means to control buoyancy, GVs are hollow protein-shelled compartments 50-500 nanometers in size that exclude water but are permeable to gas. Unlike artificial micro bubbles, GVs are not pressurized and allow gases to freely exchange with the surrounding medium. This results in a very stable nanoscale configuration enabling a broader range of potential molecular imaging applications. In preliminary results, we have demonstrated that GVs from multiple species produce stable ultrasound contrast that is readily detected in vitro, inside cells and in vivo. The
fact that GVs are genetically en- coded provides an unprecedented opportunity of engineering their properties at the genetic level to optimize their acoustics, biodistribution and targeting fo specific applications. In addition, there is the potential of adapting GVs as reporter genes - for the first time combining the ability of ultrasound to image at depth in vivo with the ability of genetic reporters to directly visualize cellular events such as gene expression. To address our hypothesis that GVs can serve as versatile molecular imaging reporters for ultrasound, we propose to develop this new class of molecular imaging agents by (1) understanding GVs' genetically en- coded acoustic properties through physical characterization and modeling, (2) using a genetic engineering plat- form to optimize GVs' acoustic, biological and targeting properties, (3) demonstrating the ability of these nanostructures to target and image extravascular tumor cells in vivo and (4) expressing GV-forming genes in mammalian cells. Successful completion of this project will result in a transformative advance in molecular imaging with ultrasound: a fundamentally new class of stable, nanosized, genetically tunable, molecularly targetable extra- vascular imaging agents, with immediate relevance in biomedical research and the potential for future clinical translation. In addition, this work will stimulate advances in biophysics, molecular and cellular engineering and imaging technology that will contribute more generally to biomedical imaging and bioengineering research.
描述(由申请人提供):超声是生物医学中最广泛使用的非侵入性成像方式之一,但由于缺乏合适的分子成像剂,在分子成像中发挥的作用令人惊讶地小。尽管常规的微泡造影剂在某些心血管疾病和癌症的非侵入性诊断中获得认可,但是它们作为微泡外的特定细胞和组织的标记物的效用有限。
因为它们的微米尺寸通常将它们限制在血流中。因此,超声尚未充分发挥其潜力,使生物医学研究和潜在的临床领域,包括癌症,免疫学,神经学和传染病方便,快速的分子成像。我们建议通过向大自然借鉴来满足这一需求。具体来说,我们将开发基于一类独特的遗传编码气体纳米结构的分子成像剂,称为气体囊泡(GV)。由水生微生物表达为控制浮力的手段,GV是中空的蛋白质壳隔室,大小为50-500纳米,排除水,但可渗透气体。与人造微气泡不同,GV不加压,允许气体与周围介质自由交换。这导致非常稳定的纳米级配置,从而能够实现更广泛的潜在分子成像应用。在初步结果中,我们已经证明,来自多个物种的GV产生稳定的超声对比度,在体外,细胞内和体内很容易检测到。的
GV被基因编码的事实提供了在基因水平上工程化其特性以优化其声学、生物分布和针对特定应用的靶向的前所未有的机会。此外,还有可能将GV作为报告基因-首次将超声在体内深度成像的能力与遗传报告基因直接可视化细胞事件(如基因表达)的能力相结合。为了解决我们的假设,即GV可以作为超声的多功能分子成像报告者,我们提出通过以下方式开发这类新的分子成像剂:(1)通过物理表征和建模来理解GV的遗传编码的声学特性,(2)使用基因工程平台来优化GV的声学、生物学和靶向特性,(3)证明这些纳米结构在体内靶向血管外肿瘤细胞并使其成像的能力和(4)在哺乳动物细胞中表达GV形成基因。该项目的成功完成将导致超声分子成像的变革性进展:一种全新的稳定,纳米尺寸,遗传可调,分子靶向血管外成像剂,与生物医学研究直接相关,并具有未来临床转化的潜力。此外,这项工作将促进生物物理学、分子和细胞工程以及成像技术的进步,从而更普遍地促进生物医学成像和生物工程研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mikhail Shapiro其他文献
Mikhail Shapiro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mikhail Shapiro', 18)}}的其他基金
International Symposium on Biomolecular Ultrasound and Sonogenetics
生物分子超声与声遗传学国际研讨会
- 批准号:
10609240 - 财政年份:2022
- 资助金额:
$ 33.95万 - 项目类别:
The Future of Molecular MR: A Cellular and Molecular MR Imaging Workshop
分子 MR 的未来:细胞和分子 MR 成像研讨会
- 批准号:
10540612 - 财政年份:2022
- 资助金额:
$ 33.95万 - 项目类别:
Ultrasonic Genetically Encoded Calcium Indicators for Whole-Brain Neuroimaging
用于全脑神经影像的超声波基因编码钙指示剂
- 批准号:
10166018 - 财政年份:2021
- 资助金额:
$ 33.95万 - 项目类别:
Sonogenetic Remote Control of Cellular Function
细胞功能的声遗传学远程控制
- 批准号:
10261864 - 财政年份:2021
- 资助金额:
$ 33.95万 - 项目类别:
Sonogenetic Remote Control of Cellular Function
细胞功能的声遗传学远程控制
- 批准号:
10488296 - 财政年份:2021
- 资助金额:
$ 33.95万 - 项目类别:
Sonogenetic Remote Control of Cellular Function
细胞功能的声遗传学远程控制
- 批准号:
10676282 - 财政年份:2021
- 资助金额:
$ 33.95万 - 项目类别:
Acoustically targeted molecular control of cell type specific neural circuits in non-human primates
非人类灵长类动物细胞类型特异性神经回路的声学靶向分子控制
- 批准号:
9804641 - 财政年份:2019
- 资助金额:
$ 33.95万 - 项目类别:
Biogenic Gas Nanostructures As Molecular Imaging Reporters For Ultrasound
生物气体纳米结构作为超声分子成像记者
- 批准号:
10318929 - 财政年份:2019
- 资助金额:
$ 33.95万 - 项目类别:
Molecular Functional Ultrasound for Non-Invasive Imaging and Image-Guided Recording and Modulation of Neural Activity
用于非侵入性成像和图像引导记录以及神经活动调节的分子功能超声
- 批准号:
9605856 - 财政年份:2016
- 资助金额:
$ 33.95万 - 项目类别:
Dissecting human brain circuits in vivo using ultrasonic neuromodulation
使用超声波神经调制在体内解剖人脑回路
- 批准号:
8828517 - 财政年份:2014
- 资助金额:
$ 33.95万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 33.95万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 33.95万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 33.95万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 33.95万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 33.95万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 33.95万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 33.95万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 33.95万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 33.95万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 33.95万 - 项目类别:
Research Grant